Selma Lejlic

Author information from the last article

Klinisk institutt

Universitetet i Bergen

Forfatterbidrag: diagnosesøk, dataplotting, statistikk og utforming og utarbeiding av manuset.

Selma Lejlic er medisinstudent. Hun har skrevet hovedoppgave om SGLT2-hemmerassosiert diabetisk ketoacidose.

Articles by Selma Lejlic

Diabetic ketoacidosis with SGLT2 inhibitor use – a patient series

Selma Lejlic,
Gunhild Holmaas,
Kristian Løvås,
Grethe Åstrøm Ueland

20.02.2023: Since their introduction in 2013, inhibitors of sodium glucose cotransporter 2 (SGLT2 inhibitors) have become a common treatment for type 2 diabetes (1). They have been shown to reduce cardiovascular mortality in this patient group and delay the progression of chronic kidney disease (2). However...